AVANT IMMUNOTHERAPEUTICS INC
AVANT IMMUNOTHERAPEUTICS INC (AVAN) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 18 transactions totaling $15.0M, demonstrating a bullish sentiment with $5.1M in net insider flow. The most recent transaction on Oct 1, 2020 involved a purchase of 1,000,000 shares valued at $10.0M.
AVAN Insider Activity Summary
Who Is Buying AVAN Stock?
No significant insider buying has been recorded for AVAN in the recent period.
Who Is Selling AVAN Stock?
No significant insider selling has been recorded for AVAN in the recent period.
Is AVANT IMMUNOTHERAPEUTICS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AVAN is bullish with an Insider Alignment Score of 67/100 and a net flow of $5.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AVAN Frequently Asked Questions
Understanding AVAN Insider Activity
Insider trading at AVANT IMMUNOTHERAPEUTICS INC (AVAN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading AVAN stock, having executed 18 transactions in the past 90 days. The most active insider is Roberto Mignone (Executive), who has made 1 transactions totaling $10.0M.
Related Tools
Track AVANT IMMUNOTHERAPEUTICS INC Insider Activity
Get notified when executives and directors at AVAN file new Form 4 transactions